Apollo Hospitals Enterprise Ltd (AHEL) on Wednesday reported a 43 per cent decline in consolidated net profit at Rs 97.01 crore for the fourth quarter of FY22. The healthcare major posted a net profit of ₹169.89 crore during the same quarter in FY2011. On a sequential basis, the company’s net profit was down over 60 per cent from ₹243.25 crore posted in the October-December quarter of FY22.
The company said the fall in profit after tax (PAT) was on account of one-time capital gains tax levied under business combination accounting.
The company reorganized its pharmacy delivery business with the company’s wholly owned subsidiary, Apollo Healthco Ltd, including the online technology platform, Apollo 24/7, and the company’s stake in the company’s subsidiary Apollo Medicals Pvt Ltd (AMPL). It came into effect on March 16, 2022. As a result, the pharmacy delivery business is classified as a ‘closed operation’ and the company is now engaged only in the healthcare business.
consolidated revenue
Consolidated revenue from operations increased 24 percent year-on-year to . ₹3,546.43 crore (₹2,867.95 crore) during Q4FY22.
On a standalone basis, the company’s PAT, which includes on and off operations, grew 33 per cent year-on-year to ₹153.67 crore (₹115.52 crore) in Q4FY22. However, the standalone PAT was down 12 per cent sequentially from ₹175.41 crore posted during Q3FY22.
For the full year, the company posted a standalone net profit of ₹665.03 crore in FY22 as against a net profit of ₹105.16 crore in the previous fiscal. However, Apollo Hospitals said the results for the year ended March 2022 are not comparable with the results for the year ended March 2021, which includes the front-end retail pharmacy business included in the Standalone Pharmacy segment, till effective data of transfer.
Published on
25 May 2022